The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
about
Lipid biomarkers of oxidative stress in a genetic mouse model of Smith-Lemli-Opitz syndromeMethod for determination of (-102C>T) single nucleotide polymorphism in the human manganese superoxide dismutase promoterMetabolomics of oxidative stress in recent studies of endogenous and exogenously administered intermediate metabolitesNeuroprotective and symptomatic effects of targeting group III mGlu receptors in neurodegenerative diseaseIncreased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits.Melatonin in Alzheimer's disease and other neurodegenerative disordersIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesInduction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins a, C, and eChemicals possessing a neurotrophin-like activity on dopaminergic neurons in primary cultureTetraspanin (TSP-17) protects dopaminergic neurons against 6-OHDA-induced neurodegeneration in C. elegansCHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonismAltered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathiesFurther structure-activity relationships study of substituted dithiolethiones as glutathione-inducing neuroprotective agentsCrystal arthritides - gout and calcium pyrophosphate arthritis : Part 1: Epidemiology and pathophysiology.JNK3 mediates paraquat- and rotenone-induced dopaminergic neuron death.The effects of nitric oxide on the oxidations of l-dopa and dopamine mediated by tyrosinase and peroxidase.Assessment of plasma lactoferrin in Parkinson's disease.Iron contributes to the formation of catechol isoquinolines and oxidative toxicity induced by overdose dopamine in dopaminergic SH-SY5Y cells.Etiology of Parkinson's disease.Ropinirole and pramipexole, the new agonists.Treatment of early Parkinson's disease.Oxysterols from free radical chain oxidation of 7-dehydrocholesterol: product and mechanistic studies.Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington's disease, Alzheimer's disease and parkinsonism.Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson diseaseSelective neuronal vulnerability to oxidative stress in the brain.Neuroprotective effects of cuscutae semen in a mouse model of Parkinson's disease.Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson's diseaseNeuromelanin in the human brain: a review and atlas of pigmented cells in the substantia nigra.The omega-class glutathione transferases: structure, function, and genetics.Enhancement of pheochromocytoma nerve cell growth by consecutive fractionization of Angelica gigas Nakai extractsNeuroprotection for Parkinson's disease: a new approach for a new millennium.Seniors with Parkinson's disease: initial medical treatment.Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis.Neocortex and allocortex respond differentially to cellular stress in vitro and aging in vivoDrosophila DJ-1 decreases neural sensitivity to stress by negatively regulating Daxx-like protein through dFOXO.Oxidative stress and level of antioxidant enzymes in drug-naive schizophrenics.Phloroglucinol attenuates motor functional deficits in an animal model of Parkinson's disease by enhancing Nrf2 activity.Melatonin in mitochondrial dysfunction and related disordersParaoxonase (PON 1) as a biomarker of susceptibility for organophosphate toxicity.
P2860
Q24615855-3A61ECEE-3F5B-4945-A25F-9AB8FE5FB184Q24799443-1A7774EF-A4E1-45C7-B92B-9D2C57C10FE7Q26824720-7F483D78-103F-405C-BFD8-0904E943E868Q26995351-9CB9AA73-91E8-42F4-A958-7DDD57A4DCEEQ27308109-2B4F521E-EEE5-4CA4-B4AA-6905A61F8BA9Q28217483-B6351973-8EF5-4A74-A108-67010DBFF0F8Q28388335-91F0FF29-5E93-4F2A-ACB7-685A080FD310Q28395954-4E5263C8-A825-431F-8C31-A45AEAB10D47Q28475734-F2C79B0A-8F65-42D1-9396-CB2C29ADA171Q28542478-6645F568-1BE1-451E-8FBB-458C4FD45399Q28579022-0FB4C821-7D8C-46E0-9323-AB63EE95EED5Q28591852-D0BA552A-13D1-4656-9029-2F0AA737239DQ28821625-2C7F5417-E033-4467-963B-3BA4B20B4C0CQ30235586-3DBEFEA1-BB6D-42C9-95B4-D05D1240126BQ30498929-89E1AD7C-7A54-41A5-94D1-C20916848007Q31797525-24314AEE-0CFC-4340-B68D-CDEF4BECCAAFQ32052230-9C83D2A2-C55B-4081-9264-2BC432AB7AD1Q33337387-FFCA3A47-C290-4F15-BB57-6A86FC570FE1Q33714108-AC9D5D37-DD59-4793-BFEC-DE7A7DB3D9D4Q33714127-2FDCDF9E-437E-4598-9727-16BC27EF010EQ33714133-A004E922-C764-4CD7-A969-40E3D1A7BDF2Q33730805-AAE73F1C-F0A5-4854-8D72-BC739F889A6CQ33834203-BC46E01C-75DE-4B92-944E-207F438DA932Q33856488-82949E81-710D-4ADE-ACAC-401E3A7B83C2Q33868370-B7F4474B-24B9-4CE9-A9C6-5C0EEF4F3397Q34032558-A4CA2B60-7DE8-42BF-9458-28D946A3E19FQ34041790-02B22A0F-2668-4330-AF54-2B8362D7A678Q34169019-B9D11771-E321-476E-867F-33B5FD30E076Q34178562-2FB59865-FE95-472C-AC65-CD5F44786689Q34361613-07F6D7D5-D3F1-4868-8EE4-2269F806A926Q34481778-05653191-8371-4152-8E2A-387C2A998944Q34508143-7C513CB6-E350-4522-BC1F-192524811C4EQ34562608-2D53DCE3-9D7B-4631-A686-CF8BBD405A48Q34629589-84EF5456-5B5E-4946-8D41-D14805923B3EQ34639246-5FD1ACD5-88F6-4B83-BB8D-A6D5C2474833Q34671965-6BC0FB40-EE13-4FE6-BB50-8A06A8226BA2Q34786239-66A03F48-F260-44BE-820E-6C5D953E1EE9Q34970674-90A555DE-276C-4629-9B3B-5681FE15D6EFQ35001051-9678CDDE-7C33-40C4-A0E8-414F75BE2E38Q35041945-C47F8168-EC8F-4EC3-B073-64EFDBF4BF10
P2860
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
@ast
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
@en
type
label
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
@ast
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
@en
prefLabel
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
@ast
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
@en
P356
P1433
P1476
The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.
@en
P2093
P304
P356
10.1002/ANA.410320616
P50
P577
1992-12-01T00:00:00Z